CytoSorbents REFRESH 2-AKI Protocol Amendment Approved by FDA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Cytosorbents Corporation (NASDAQ: CTSO) | Delayed: 5.27 -0.74 (12.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.01 | 52 Week High | $7.48 | |||
| Open | $5.90 | 52 Week Low | $3.11 | |||
| Day High | $5.96 | P/E | N/A | |||
| Day Low | $5.22 | EPS | $-0.03 | |||
| Volume | 42,648 | |||||
